Enliven Therapeutics, Inc.
Industry: Life Sciences ・ $ELVN on Nasdaq
Insider Sale
+$22,520
-7.14%
Shares
Shares Volume: 1,000 Shares
Average Share Price: $22.52
INSIDER
Hohl Benjamin
CHIEF FINANCIAL OFFICER (Officer)
reported on Feb 7 2025
traded on Feb 5 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 13,000 |
| PURCHASES/SALES 1Y | 0 / 21 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $100,279.31 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 85 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $880,102.58 |
| COMPANY PREVIOUS TRADES |